- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.96 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
H4B.2: 13 residues within 4Å:- Chain A: S.62, V.64, R.325, A.406, W.407
- Chain B: W.34, W.405, F.420, H.421, Q.422, E.423
- Ligands: HEM.1, KLD.3
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.325, A:R.325, A:A.406, A:W.407
- pi-Stacking: A:W.407, A:W.407
- pi-Cation interactions: A:W.407
- Hydrophobic interactions: B:E.423
H4B.13: 12 residues within 4Å:- Chain A: W.34, W.405, F.420, H.421, Q.422, E.423
- Chain B: S.62, V.64, A.406, W.407
- Ligands: HEM.12, KLD.14
6 PLIP interactions:5 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:A.406, B:W.407
- pi-Stacking: B:W.407, B:W.407
- pi-Cation interactions: B:W.407
- Hydrophobic interactions: A:E.423
- 2 x KLD: 6-[2-(3-fluoro-5-{2-[(2R,4S)-4-fluoro-1-methylpyrrolidin-2-yl]ethyl}phenyl)ethyl]-4-methylpyridin-2-amine(Non-covalent)
KLD.3: 15 residues within 4Å:- Chain A: V.64, F.65, P.294, V.296, F.313, S.314, G.315, W.316, Y.317, M.318, E.321, W.407, Y.435
- Ligands: HEM.1, H4B.2
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:V.64, A:P.294, A:V.296, A:F.313, A:W.407
- Hydrogen bonds: A:M.318, A:E.321, A:Y.435
KLD.14: 16 residues within 4Å:- Chain B: V.64, F.65, P.294, V.296, F.313, S.314, G.315, W.316, Y.317, M.318, E.321, R.325, W.407, Y.435
- Ligands: HEM.12, H4B.13
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:P.294, B:F.313, B:W.407
- Hydrogen bonds: B:M.318, B:E.321
- 8 x BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
BTB.4: 3 residues within 4Å:- Chain A: V.341, C.342, D.344
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:V.341, A:D.344
BTB.5: 2 residues within 4Å:- Chain A: E.337, T.347
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.337
- Salt bridges: A:E.337
BTB.6: 1 residues within 4Å:- Chain A: E.258
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:E.258
BTB.11: 4 residues within 4Å:- Chain A: V.341, D.344, L.345, R.348
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:V.341, A:D.344, A:T.347, A:T.347
- Salt bridges: A:D.344
BTB.15: 3 residues within 4Å:- Chain B: T.279, E.281
- Ligands: GD.19
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.281, B:E.281
- Salt bridges: B:E.281
BTB.16: 2 residues within 4Å:- Chain B: D.257, E.258
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.257, B:E.258
- Salt bridges: B:E.258
BTB.17: 2 residues within 4Å:- Chain B: E.337, D.338
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:E.337
- Water bridges: B:N.334, B:N.334, B:E.337
- Salt bridges: B:D.338
BTB.20: 1 residues within 4Å:- Chain B: D.344
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.344
- Salt bridges: B:D.344
- 2 x ZN: ZINC ION(Non-covalent)
ZN.7: 4 residues within 4Å:- Chain A: C.54, C.59
- Chain B: C.54, C.59
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Metal complexes: A:C.54, A:C.59, B:C.54, B:C.59
ZN.10: 2 residues within 4Å:- Chain A: H.421
- Chain B: D.329
5 PLIP interactions:1 interactions with chain A, 2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: A:H.421, B:D.329, B:D.329, H2O.9, H2O.11
- 1 x GOL: GLYCEROL(Non-functional Binders)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x GD: GADOLINIUM ATOM(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Do, H.T. et al., Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold. J. Med. Chem. (2019)
- Release Date
- 2019-03-13
- Peptides
- Endothelial nitric oxide synthase splice variant eNOS13A: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
SMTL ID : 6nh5.1 (1 other biounit)
Structure of human endothelial nitric oxide synthase heme domain in complex with 6-(3-fluoro-5-(2-((2R,4S)-4-fluoro-1-methylpyrrolidin-2-yl)ethyl)phenethyl)-4-methylpyridin-2-amine
Endothelial nitric oxide synthase splice variant eNOS13A
Related Entries With Identical Sequence
4d1o.1 | 4d1p.1 | 5uo8.1 | 5uo8.2 | 5uo9.1 | 5uo9.2 | 5uoa.1 | 5uob.1 | 5uob.2 | 5uoc.1 | 5uoc.2 | 5vvb.1 | 5vvb.2 | 5vvc.1 | 5vvc.2 | 5vvd.1 | 5vvd.2 | 6av6.1 | 6av6.2 | 6av7.1 | 6av7.2 | 6cie.1 | 6cie.2 | 6cif.1 | 6cif.2 | 6nh1.1 | 6nh1.2 | 6nh2.1 | 6nh2.2 | 6nh3.1 more...less...6nh3.2 | 6nh4.1 | 6nh4.2 | 6nh5.2 | 6nh6.1 | 6nh6.2 | 6nh7.1 | 6nh8.1 | 6nh8.2 | 6nhf.1 | 6nhf.2 | 6pou.1 | 6pou.2 | 6pou.3 | 6pov.1 | 6pov.2 | 6pow.1 | 6pow.2 | 6pox.1 | 6pox.2 | 6poy.1 | 6poy.2 | 6poz.1 | 6poz.2 | 6pp0.1 | 6pp0.2 | 6pp1.1 | 6pp1.2 | 6pp2.1 | 6pp2.2 | 6pp3.1 | 6pp3.2 | 6pp4.1 | 6pp4.2 | 7m56.1 | 7tsg.1 | 7tsg.2 | 7tsh.1 | 7tsh.2 | 7tsi.1 | 7tsi.2 | 7tsk.1 | 7tsk.2 | 7tsl.1 | 7tsl.2 | 7tsm.1 | 7tsm.2 | 7tsn.1 | 7tsn.2 | 7tso.1 | 7tso.2 | 7tsp.1 | 7tsp.2 | 7uao.1 | 7uao.2 | 8fgn.1 | 8fgn.2 | 8fgo.1 | 8fgo.2 | 8fgp.1 | 8fgp.2 | 8fgq.1 | 8fgq.2 | 8fgr.1 | 8fgr.2 | 8fgs.1 | 8fgs.2 | 8fgt.1 | 8fgt.2 | 8fgu.1 | 8fgu.2 | 8ufr.1 | 8ufr.2 | 8ufu.1 | 8ufu.2